Please login to the form below

antifungal

This page shows the latest antifungal news and features for those working in and with pharma, biotech and healthcare.

UK biotech bags €1.5m grant for new antibiotic class

Last week, Scottish biotech NovaBiotics was awarded a £1.8m grant from Innovate UK to help support the development of Novamycin, a first-in-class antifungal compound with potential to combat

Latest news

Insmed claims first FDA okay for limited population antibiotic

The Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) was set up in 2016 to encourage and hasten the development of new antibiotics or antifungals for that address a limited
GSK and Novartis lead at PM Society Digital Awards

Bayer, MSD and Teva all picked up a gold each, for work that included multichannel work in hypogonadism and budget modelling in antifungal prophylaxis.
Basilea bags $72m upfront from Pfizer for antifungal license

Swiss pharma company Basilea has signed up Pfizer as its commercial partner for new antifungal Cresemba in Europe, Russia, Turkey and Israel, hoping to accelerate sales of the drug. ... Basilea launched the antifungal in its first European markets last
Rare disease therapies head the ‘class of 2015’

isavuconazole. Cresemba. Invasive aspergillosis/mucomycosis. triazole antifungal. Basilea/Astellas. USA. ixazomib. Ninlaro. multiple myeloma.
FDA approves first female sexual disorder drug

The warning also extends to women who use other drugs that are moderate or strong inhibitors of the drug metabolising enzyme - a group which includes certain antibiotics and antifungals, HIV drugs

More from news
Approximately 3 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

Basilea has granted an exclusive licence for isavuconazole (an iv and oral antifungal for invasive aspergillosis and mucomycosis) to Asahi Kasei in Japan.
Astellas: Ten years young

class of OAB treatments to emerge in over 30 years, the antifungal Mycamine (micafungin) and the anti-infective Dificlir - the first new treatment in 50 years for clostridium difficile or c.
Medius Deal Watch table for March 2015

109. Astellas / Vical. Licence and collaboration. Preclinical antifungal ASP2397. 100.
Pharma deals during October 2013

This proved to be the case with Dow Pharmaceutical Sciences, which had undertaken development work for Anacor on the topical antifungal tavaborole for the treatment of onychomycosis under a 2004 master

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

AstraZeneca’s John Rex joins UK biotech F2G

new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials. ... John Rex said: “I am delighted to have the opportunity to work more closely with F2G as we take the first orotomide antifungal
F2G appoints chief financial officer

Schmid brings over two decades of financial management experience to the antifungal drug discovery and development company, with particular expertise in mergers and acquisitions, licensing and public and private market transactions.
Cidara Therapeutics makes senior appointments

Balkovec has helped bring more than a dozen development candidates into clinical development, including the first approved echinocandin antifungal drug Cancidas (caspofungin), which he is additionally co-inventor of.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Client Services Director- Flexible Working: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager – Healthcare advertising: Salary TBC

Senior Medical Writer: Competitive salary plus benefits

Events Executive: DOE

Subscribe to our email news alerts

PMHub

Add my company

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...